John M. Leonard, President and CEO at Intellia Therapeutics, Inc. (NTLA), sold 35,000 shares at $38.00 ($1.4M) on 2020-11-27, disclosed to the SEC on 2020-11-27.
Open-market sale of $1.4M NTLA by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $38.00 | 15,000 | $570K | 42.2% |
| 2 | $39.00 | 20,000 | $780K | 57.8% |
| Total | $38.57 avg | 35,000 | $1.4M | 100% |
| Filing → |
| NTLA | SELL | 2025-12-12 | $1.7M | — | Filing → |
| NTLA | SELL | 2025-01-07 | $653K | — | Filing → |
| NTLA | SELL | 2024-01-05 | $1.1M | — | Filing → |